Review proposes developmental senescence misregulation as a model for CHARGE syndrome
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThis peer-reviewed review argues that misregulation of developmental senescence, a physiological program in vertebrate embryos, may contribute to congenital defects, and proposes CHD7 deficiency in CHARGE syndrome as a candidate model. The authors describe this as a hypothesis supported by evidence in vertebrate models. [1]
The review argues that misregulated developmental senescence may be a source of congenital defects and proposes CHD7 deficiency in CHARGE syndrome as a candidate model. [1]
In vertebrate models, CHD7 expression domains during development largely overlap with regions where physiological embryonic senescence has been described. [1]
CHD7 reduction is associated with altered cell proliferation and misregulation of senescence-related pathways including p53, p21 and TGFβ. [1]
Review proposes senescence misregulation in congenital disorders
The description presents a review published in Aging on September 8, 2026, in Volume 18, by researchers from several Spanish institutions. The authors argue that developmental senescence, a physiological program contributing to tissue remodeling, morphogenesis and growth regulation during vertebrate embryogenesis, requires strict spatial and temporal control. When misregulated, they suggest, it may be a source of congenital defects. They propose CHD7 deficiency, the major genetic cause of CHARGE syndrome, as a candidate model. [1]
CHD7 overlap and senescence pathway evidence in models
According to the description, the hypothesis rests on several lines of evidence in vertebrate models. First, CHD7 expression domains during development largely overlap with regions where physiological embryonic senescence has been described. Second, CHD7 reduction is associated with altered cell proliferation and misregulation of key senescence-related pathways, including those driven by p53, p21 and TGFβ. The authors suggest that disrupting this regulatory balance may alter the timing of cellular growth arrest, clearance and tissue differentiation, offering a plausible mechanistic framework for the multisystemic anomalies seen in CHARGE syndrome. [1]
Hypothesis framed as candidate model, not established cause
The description frames these points as an argument and a hypothesis, not as demonstrated causation. The supporting evidence comes from vertebrate models, and the proposed mechanistic framework is described as plausible. The description does not report a study design, sample, follow-up or measured outcomes in patients, and it does not establish that developmental senescence misregulation causes CHARGE syndrome. [1]
Context & limits
This is based only on the video description; the video and transcript were not reviewed. The description presents a hypothesis supported by vertebrate-model evidence, not demonstrated causation in patients, and reports no study design, sample or measured outcomes.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
represents a source of congenital defects
CHD7 expression domains during development largely overlap
CHD7 reduction is associated with altered cell
About this video
Creator description · original textText language: English
Aging Journal · 2 min · Source published: 2026-09-29
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.